Zinnat 125mg/5ml granules for oral suspension

Maa: Malta

Kieli: englanti

Lähde: Medicines Authority

Aktiivinen ainesosa:

CEFUROXIME

Saatavilla:

Glaxo SmithKline Ireland Limited 12, Riverwalk, Citywest Business Campus, Dublin 24, Ireland

ATC-koodi:

J01DC02

INN (Kansainvälinen yleisnimi):

CEFUROXIME

Lääkemuoto:

GRANULES FOR ORAL SUSPENSION

Koostumus:

CEFUROXIME 125 milligram(s)/5 millilitre

Prescription tyyppi:

POM

Terapeuttinen alue:

ANTIBACTERIALS FOR SYSTEMIC USE

Valtuutuksen tilan:

Authorised

Valtuutus päivämäärä:

2006-09-15

Pakkausseloste

_ _
Page 1 of 8
PACKAGE LEAFLET: INFORMATION FOR THE USER
ZINNAT 125 MG/5 ML GRANULES FOR ORAL SUSPENSION
ZINNAT 250 MG/5 ML GRANULES FOR ORAL SUSPENSION
cefuroxime
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist or
nurse.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist or
nurse. This includes any
possible side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
:
1.
What Zinnat is and what it is used for
2.
What you need to know before you take Zinnat
3.
How to take Zinnat
4.
Possible side effects
5.
How to store Zinnat
6.
Contents of the pack and other information
1.
WHAT ZINNAT IS AND WHAT IT IS USED FOR
Zinnat is an antibiotic used in adults and children. It works by
killing bacteria that cause infections.
It belongs to a group of medicines called
_cephalosporins_
.
Zinnat is used to treat infections of:
•
the throat
•
sinus
•
middle ear
•
the lungs or chest
•
the urinary tract
•
the skin and soft tissues.
Zinnat can also be used:
•
to treat Lyme disease (an infection spread by parasites called ticks).
Your doctor may test the type of bacteria causing your infection and
monitor whether the bacteria
are sensitive to Zinnat during your treatment.
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE ZINNAT
DO NOT TAKE ZINNAT:
•
IF YOU ARE ALLERGIC
to cefuroxime or
ANY CEPHALOSPORIN ANTIBIOTICS,
or any of the other
ingredients of Zinnat (listed in section 6).
•
if you have ever had a severe allergic (hypersensitive) reaction to
any other type of betalactam
antibiotic (penicillins, monobactams and carbapenems).
➔
If you think this applies to you,
DON’T TAKE ZINNAT
until you have checked with your doctor.
_ _
Page 2 of 8
WARNI

Valmisteyhteenveto

Page
1
of
19
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE MEDICINAL PRODUCT
Zinnat 250 mg film-coated tablets
Zinnat 500 mg film-coated tablets
Zinnat 125 mg/5 ml granules for oral suspension
Zinnat 250 mg/5 ml granules for oral suspension
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Zinnat 250 mg film-coated tablets
Each tablet contains 250mg cefuroxime (as cefuroxime axetil).
Zinnat 500 mg film-coated tablets
Each tablet contains 500mg cefuroxime (as cefuroxime axetil).
Zinnat 125 mg/5 ml granules for oral suspension
125 mg cefuroxime per 5 ml (as 150 mg cefuroxime axetil)
Zinnat 250 mg/5 ml granules for oral suspension
250 mg cefuroxime per 5 ml (as 300 mg cefuroxime axetil)
Excipient(s) with known effect:
Zinnat 250 mg film-coated tablets
Each tablet contains 0.00203mg sodium benzoate (E211)
Each tablet contains Methyl parahydroxybenzoate (E218) and Propyl
parahydroxybenzoate (E216)
Zinnat 500 mg film-coated tablets
Each tablet contains 0.00506mg sodium benzoate (E211)
Each tablet contains Methyl parahydroxybenzoate (E218) and Propyl
parahydroxybenzoate (E216)
Zinnat 125 mg/5 ml granules for oral suspension
Contains 0.021 g aspartame (E951) per 5 ml dose
Contains 3.1 g of sucrose per 5 ml dose
Contains 6 mg of propylene glycol (E1520) per 5 ml dose
Contains 4.5 mg benzyl alcohol (E1519) per 5 ml dose
Zinnat 250 mg/5 ml granules for oral suspension
Contains 0.045 g aspartame (E951) per 5 ml dose
Contains 2.3 g of sucrose per 5 ml dose
Contains 4.6 mg benzyl alcohol (E1519) per 5 ml dose
For the full list of excipients, see section 6.1.
Page
2
of
19
3.
PHARMACEUTICAL FORM
250 mg, 500 mg film-coated tablets
Film-coated tablet (tablet)
125 mg/5 ml, 250 mg/5 ml granules for oral suspension
Granules for oral suspension
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Zinnat is indicated for the treatment of the infections listed below
in adults and
children from the age of 3 months (see sections 4.4 and 5.1).

Acute streptococcal tonsillitis and pharyngitis.

Acute bacterial sinusitis.

Acute otitis